体重指数对子宫内膜癌机器人手术结局的影响
这项回顾性研究纳入2007年12月至2022年12月在一家三级癌症中心连续接受机器人手术的1329例子宫内膜癌患者,按体重指数(BMI)分层比较围手术期结局。结果显示术后并发症率、转开腹率、麻醉后监护室停留和住院时间在各BMI组间无显著差异,BMI≥40.0组中位估计出血量和手术室时间略高但无临床相关性;作者结论为BMI不影响子宫内膜癌机器人分期手术的围手术期结局。
要点
- 1329例子宫内膜癌患者按BMI<30.0、30.0-39.9、≥40.0分为三组,分别占43.3%、33.8%、22.9%。
- 术后并发症率8.0%至9.5%(p=0.761)、转开腹率0.7%至1.0%(p=0.885),各组间相似。
- BMI≥40.0组中位估计出血量30 mL vs 20 mL、中位手术室时间288 min vs 270 min,均较高但无临床相关性。
核心结论
- 作者结论为BMI不影响接受机器人分期手术的子宫内膜癌患者的围手术期结局。
研究设计与样本
- 回顾性研究,纳入2007年12月至2022年12月在一家三级癌症中心连续接受机器人手术的全部子宫内膜癌患者,共1329例。
- 按BMI分层:<30.0(n=576;43.3%)、30.0-39.9(n=449;33.8%)、≥40.0(n=304;22.9%)。
- 采用Kruskal-Wallis检验比较BMI组间差异,采用卡方检验分析分类变量间的关联。
主要发现
- 麻醉后监护室(PACU)停留时间(p=0.105)和住院时间(p=0.497)在各组间无显著差异。
- 术后并发症率在各组间相似,范围为8.0%至9.5%(p=0.761)。
- 转开腹率在各组间也相似,范围为0.7%至1.0%(p=0.885)。
- BMI≥40.0组中位估计出血量较高(30 mL vs 20 mL;p<0.001),中位手术室(OR)时间较长(288 min vs 270 min;p<0.001),原文称无临床相关性。
- 手术室时间中,BMI较高组中位准备时间较长(58 min vs 50 min;p<0.001),而切皮至缝合时间(209 min vs 203 min;p=0.202)和术后时间(14 min vs 13 min;p=0.094)组间相当。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare surgical outcomes of patients with endometrial cancer who underwent robotic surgery across different BMI categories. METHODS: A retrospective study including all consecutive patients with endometrial cancer who underwent robotic surgery at a tertiary cancer center between December 2007 and December 2022. The study analyzed outcome measures, including blood loss, surgical times, length of hospitalization, perioperative complications, and conversion rates with the Kruskal-Wallis test for BMI group differences and the Chi-squared test for associations between categorical variables. RESULTS: A total of 1329 patients with endometrial cancer were included in the study. Patients were stratified by BMI: <30.0 (n = 576; 43.3%), 30.0-39.9 (n = 449; 33.8%), and ≥ 40.0 (n = 304; 22.9%). There were no significant differences in post-anesthesia care unit (PACU) stay (p = 0.105) and hospital stay (p = 0.497) between the groups. The rate of post-op complications was similar across the groups, ranging from 8.0% to 9.5% (p = 0.761). The rate of conversion to laparotomy was also similar across the groups, ranging from 0.7% to 1.0% (p = 0.885). Women with a BMI ≥40.0 had a non-clinically relevant but greater median estimated blood loss (30 mL vs. 20 mL; p < 0.001) and longer median operating room (OR) time (288 min vs. 270 min; p < 0.001). Within the OR time, the median set-up time was longer for those with a higher BMI (58 min vs. 50 min; p < 0.001). However, skin-to-skin time (209 min vs. 203 min; p = 0.202) and post-op time (14 min vs. 13 min; p = 0.094) were comparable between groups. CONCLUSION: BMI does not affect the peri-operative outcome of patients undergoing robotic staging procedures for endometrial cancer.
引用
- Kadoch E, Brezinov Y, Levin G, et al. The impact of body mass index on robotic surgery outcomes in endometrial cancer. Gynecol Oncol. 2024. PMID: 38368813. doi:10.1016/j.ygyno.2024.01.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。